Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y)

Bernadet T. Santema, Michelle M.Y. Chan, Jasper Tromp, Martin Dokter, Haye H. van der Wal, Johanna E. Emmens, Janny Takens, Nilesh J. Samani, Leong L. Ng, Chim C. Lang, Peter van der Meer, Jozine M. ter Maaten, Kevin Damman, Kenneth Dickstein, John G. Cleland, Faiez Zannad, Stefan D. Anker, Marco Metra, Pim van der Harst, Rudolf A. de BoerDirk J. van Veldhuisen, Michiel Rienstra, Carolyn S.P. Lam, Adriaan A. Voors*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

Original languageEnglish
Pages (from-to)1351
Number of pages1
JournalClinical Research in Cardiology
Volume110
Issue number8
DOIs
Publication statusPublished - Aug 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).

Fingerprint

Dive into the research topics of 'Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y)'. Together they form a unique fingerprint.

Cite this